Evidence map›Paper›PMID 31128791›Full record

ArticleMethods in enzymology2019

Direct cloning and heterologous expression of natural product biosynthetic gene clusters by transformation-associated recombination.

Jia Jia Zhang, Kazuya Yamanaka, Xiaoyu Tang, Bradley S Moore

Abstract read
In one paragraph

Article in Methods in enzymology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. CRISPR-aided genome engineering for secondary metabolite biosynthesis in Streptomyces.Journal of industrial microbiology & biotechnology · 2024
    Review
  12. Review
  13. Review
  14. Article
  15. Journal of microbiology and biotechnology · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jia Jia ZhangCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California at San Diego, La Jolla, San Diego, CA, United States.
Kazuya YamanakaDepartment of Life Science and Technology, Kansai University, Osaka, Japan.
Xiaoyu TangCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California at San Diego, La Jolla, San Diego, CA, United States. Electronic address: xtang@microbechembio.org.
Bradley S MooreCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California at San Diego, La Jolla, San Diego, CA, United States; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, San Diego, CA, United States. Electronic address: bsmoore@ucsd.edu.

Funding

Natural Product Genome MiningR01GM085770 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JENSEN, PAUL R, MOORE, BRADLEY S · 2009 to 2024
$5.8M
Targeted discovery of antibiotics from cave bacteriaR01AI117712 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOORE, BRADLEY S, POGLIANO, JOSEPH A · 2016 to 2019
$2.8M
New Genetic Tools for Accessing Anti-Infective Agents from Gram-Negative BacteriaF31AI129299 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHANG, JAMIE · 2017 to 2019
$89k
NIAID NIH HHS F31 AI129299NIAID NIH HHS R01 AI117712NIGMS NIH HHS R01 GM085770
6 · The paper itself

Abstract

Heterologous expression of natural product biosynthetic gene clusters (BGCs) is a robust approach not only to decipher biosynthetic logic behind natural product (NP) biosynthesis, but also to discover new chemicals from uncharacterized BGCs. This approach largely relies on techniques used for cloning large BGCs into suitable expression vectors. Recently, several whole-pathway direct cloning approaches, including full-length RecE-mediated recombination in Escherichia coli, Cas9-assisted in vitro assembly, and transformation-associated recombination (TAR) in Saccharomyces cerevisiae, have been developed to accelerate BGC isolation. In this chapter, we summarize a protocol for TAR cloning large NP BGCs, detailing the process of choosing TAR plasmids, designing pathway-specific TAR vectors, generating yeast spheroplasts, performing yeast transformation, and heterologously expressing BGCs in various host strains. We believe that the established platforms can accelerate the process of discovering new NPs, understanding NP biosynthetic logic, and engineering biosynthetic pathways.

Indexed as

Multigene FamilyRecombination, GeneticBacillotaBacteriaBiological ProductsBiosynthetic PathwaysCloning, MolecularGenetic EngineeringMicromonosporaceaeProteobacteriaSaccharomyces cerevisiaeStreptomycesBiological ProductsBiosynthesisHeterologous expressionNatural productsYeast homologous recombination

Identifiers

PMID31128791
PMCPMC6555405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.